Phosphoric Acid

Phosphoric Acid

SCHEMBL192007

CCN(CC)CC.O=P(O)(O)O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 4/20 0.46
MMP2 P08253 3/20 0.46
MMP1 P03956 2/20 0.46
MMP3 P08254 2/20 0.46
MMP8 P22894 2/20 0.46
CA2 P00918 1/20 0.38
LAP3 P28838 1/20 0.35
LMNA P02545 1/20 0.35
PPIP5K2 O43314 1/20 0.34
LPAR3 Q9UBY5 3/20 0.33
KDM4E B2RXH2 1/20 0.33
THRB P10828 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
LPAR2 Q9HBW0 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL28801115 1.00 FDPS (0.46) FDPSMMP2MMP1MMP3MMP8
Phosphoric Acid SCHEMBL16093844 1.00 FDPS (0.46) FDPSMMP2MMP1MMP3MMP8
Phosphoric Acid SCHEMBL192006 1.00 FDPS (0.46) FDPSMMP2MMP1MMP3MMP8
Phosphoric Acid SCHEMBL1019439 1.00 FDPS (0.46) FDPSMMP2MMP1MMP3MMP8
Phosphoric Acid SCHEMBL9359318 1.00 FDPS (0.46) FDPSMMP2MMP1MMP3MMP8
Phosphoric Acid SCHEMBL21359160 1.00 FDPS (0.46) FDPSMMP2MMP1MMP3MMP8
Phosphoric Acid SCHEMBL23751823 0.97 FDPS (0.43) FDPSMMP2MMP1MMP3MMP8
Phosphoric Acid SCHEMBL8575235 0.97 FDPS (0.43) FDPSMMP2MMP1MMP3MMP8
Phosphoric Acid SCHEMBL28610245 0.97 FDPS (0.43) FDPSMMP2MMP1MMP3MMP8
Phosphoric Acid SCHEMBL28500444 0.97 FDPS (0.43) FDPSMMP2MMP1MMP3MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3037 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630586-B2 Process for the preparation of plecanatide AURO PEPTIDES LTD (IN) 2026-05-19 US claimed
US-12577274-B2 Manufacture of glucagon peptides BACHEM HOLDING AG (CH) 2026-03-17 US claimed
US-20260035406-A1 SYNTHESIS OF GLP-1R/GIPR AGONISTS CARMOT THERAPEUTICS INC. (US) 2026-02-05 US claimed
EP-4658834-A1 WET ETCH FORMULATIONS AND RELATED METHODS Entegris, Inc. (US) 2025-12-10 EP claimed
EP-3822259-B1 METHOD FOR SYNTHESIZING VALSARTAN ZHEJIANG HUAHAI PHARM CO LTD (CN) 2025-08-27 EP claimed
CN-120022522-A Drug-loaded microneedle, drug-loaded microneedle patch and electrically-controlled drug release microneedle system 成都邦迈医创科技有限公司 2025-05-23 CN claimed
CN-119822677-A Phosphogypsum reinforcing agent based on chip sludge and preparation and use methods thereof 武汉理工大学 2025-04-15 CN claimed
EP-4507722-A1 NANOEMULSION UNIVERSAL INFLUENZA VACCINE Bluewillow Biologics, Inc. (US) 2025-02-19 EP claimed
CN-119331478-A Water-based heat-resistant paint, preparation method and application 金隅微观(沧州)化工有限公司 2025-01-21 CN claimed
CN-119306779-A R-configuration-containing initial capping oligonucleotide primer and synthesis method thereof 上海科泽永欣生物科技有限公司 2025-01-14 CN claimed
EP-0763061-B1 PROCESS AND INTERMEDIATE PRODUCTS FOR PREPARING CARDIODILATIN FRAGMENTS, AND HIGHLY PURIFIED CARDIODILATIN FRAGMENTS FORSSMANN WOLF GEORG (DE) 2002-10-30 EP claimed
EP-0515228-B1 Essentially pure human parathyroid hormone ASTRA AB (SE) 1998-03-25 EP claimed
US-5290920-A Method of purifying human epidermal growth factor ALLELIX BIOPHARMACEUTICALS INC. (CA) 1994-03-01 US claimed
WO-1993021224-A1 ULTRAPURE HUMAN EPIDERMAL GROWTH FACTOR ALLELIX BIOPHARMACEUTICALS INC. (CA) 1993-10-28 WO claimed
US-5208041-A Bone disorder treatment ALLELIX BIOPHARMACEUTICALS INC. (CA) 1993-05-04 US claimed
EP-0515228-A2 Essential pure human parathyroid hormone Allelix Biopharmaceuticals Inc. (CA) 1992-11-25 EP claimed
EP-0233645-A2 Purification of growth hormone releasing factor from yeast strains producing same PHILLIPS PETROLEUM COMPANY (US) 1987-08-26 EP claimed
US-4541037-A IN CONTACT WITH ELECTROLYTE CONTAINING PHOSPHATE SALT SPRAGUE ELECTRIC COMPANY (US) 1985-09-10 US claimed
US-4377482-A Mobile phase for liquid chromatography SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 1983-03-22 US claimed
US-4247328-A TRISODIUM CITRATE, AMINE PHOSPHATES VICKERS LIMITED (GB) 1981-01-27 US claimed